Atlas Trials

A Phase IIa Study With Escalating Dose of MS1819-SD

Clinical trial NCT03481803 · COMPLETED

Trial details

NCT number
NCT03481803
Sponsor
AzurRx SAS
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic PancreatitisDistal Pancreatectomy
Start date
2017-01-27
Primary completion
2018-06-29
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.